<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJO</journal-id><journal-title-group><journal-title>Open Journal of Orthopedics</journal-title></journal-title-group><issn pub-type="epub">2164-3008</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojo.2020.107019</article-id><article-id pub-id-type="publisher-id">OJO-101627</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Treatment of Unicameral and Aneurysmal Bone Cysts by Minimally Invasive Percutaneous Injection of Grafton DBF Putty Using the Kyphon Cement Delivery System
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>G.</surname><given-names>Ulrich Exner</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pascal</surname><given-names>A. Schai</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Luzerner Kantonsspital Wolhusen, Wolhusen, Switzerland</addr-line></aff><aff id="aff1"><addr-line>Orthopaedie Zentrum Zuerich, Zuerich, Switzerland</addr-line></aff><pub-date pub-type="epub"><day>16</day><month>07</month><year>2020</year></pub-date><volume>10</volume><issue>07</issue><fpage>143</fpage><lpage>151</lpage><history><date date-type="received"><day>12,</day>	<month>June</month>	<year>2020</year></date><date date-type="rev-recd"><day>18,</day>	<month>July</month>	<year>2020</year>	</date><date date-type="accepted"><day>21,</day>	<month>July</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Simple Unicameral and Aneurysmal Bone Cysts are benign lesions that may heal spontaneously especially after fracture which may be the first symptom. However, often size increases causing pain, and complications of fractures can severely compromise the patient.
   Aim: The results in a series of cases treated minimally invasive using a new device for the application of allogenic bone material appear highly promising and shall be presented. 
  Patients and Methods: Eight consecutive patients with symptomatic Unicameral Bone Cysts (UBC) were treated by percutaneous instillation of Grafton
  &amp;reg; DBF Putty (demineralised allogenic bone containing fibers) mixed with autologous bone marrow using the Kyphon
  &amp;reg; Cement Delivery System (Medtronic), which allows the injection of this high viscosity paste by controlled high pressure. Five patients with Aneurysmal Bone Cysts (ABC) were treated accordingly after inactivation by Aethoxysclerol 3% and lacking bone formation. Using this approach a high rate of bone regeneration was observed in these patients at 8 months to 5 years follow-up (f/u). 
  Conclusion: The presented technique of a minimally invasive biologic treatment led to highly satisfying results using the Grafton
  &amp;reg; DBF Putty with its higher potential for bone regeneration than demineralized bone matrix not containing fibres (DBM).
 
</p></abstract><kwd-group><kwd>Simple Unicameral Bone Cyst</kwd><kwd> Aneurysmal Bone Cyst</kwd><kwd> DBF Putty</kwd><kwd> Kyphon Cement Delivering System</kwd><kwd> Bone Marrow</kwd><kwd> Percutaneous Treatment</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Unicameral Bone Cysts (UBC) are benign lesions with poorly understood etiology. They may resolve spontaneously typically after pathologic fracture and with advancing age; however they can be recalcitrant even after puberty.</p><p>Treatment is needed in symptomatic patients depending on size, location and fracture or threatened fracture.</p><p>Aneurysmal Bone Cysts (ABC) are neoplasias typically containing USP6-rearrangements. Good results and spontaneous healing can be achieved by injection of alcoholic solutions. However, often additional measures are needed for restitution of the bony defect.</p><p>We wish to communicate a minimally invasive technique to induce healing of these persistent cystic bone defects injecting the highly viscous paste of Grafton<sup>&#226;</sup> DBF Putty (demineralised allogenic bone containing fibers) mixed with autologous bone marrow (BM), using the Kyphon<sup>&#226;</sup> Cement Delivering System (Medtronic) resulting in a high rate of bone regeneration.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>Eight consecutive patients with symptomatic large UBC (humerus, pelvis, femur, calcaneus, <xref ref-type="table" rid="table1">Table 1</xref>), recurrent after different procedures, were treated since 2016 by the technique presented. Five patients with ABC (pubic bone, femoral neck, tibia, <xref ref-type="table" rid="table2">Table 2</xref>) not showing bone remodeling at a minimum follow-up of 3 months after inactivation by Aethoxysclerol 3% were treated accordingly. Biopsies taken at filling with Grafton<sup>&#226;</sup> DBF Putty in these cases proved no remnants of pathologic tissue. Further details of the otherwise healthy patients aged 15 to 27 years are given in <xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>Two 8G Jamshidi needles CareFusion<sup>&#226;</sup> are inserted under fluoroscopy or computer tomography (CT) to have 2 portals—one for injection, the other for “ventilation”. After aspiration of the cystic fluid content radio opaque dye (Iopamiro<sup>&#226;</sup>) is injected to document its distribution within the cavity and to exclude extraosseous leakage as described in detail by Rougraff and Kling [<xref ref-type="bibr" rid="scirp.101627-ref1">1</xref>]. Grafton<sup>&#226;</sup> DBF Putty (3 to 40 cc) was mixed with bone marrow aspirate in the relation of about 2:1 to 1:1 (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="table" rid="table2">Table 2</xref>). Bone marrow aspirate (each sample maximally 5 cc) is taken from various pelvic locations to provide sufficient osteoblastic progenitor cells [<xref ref-type="bibr" rid="scirp.101627-ref2">2</xref>]. The bone marrow aspirate is mixed with DBF and this highly viscous paste is then injected using the Kyphon<sup>&#226;</sup> Cement Delivering System providing the well controlled high pressure under image intensifier control (CT in special locations) of the extrusion of the contrast dye through the ventilation needle (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec><sec id="s3"><title>3. Results</title><p>There was sufficient incorporation/restitution of bone in 11 patients at a minimum follow-up time of 8 months. In 2 patients a second intervention (1 UBC at 5 years, 1 ABC at 2 years following the first one) was successful. No patients</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Unicameral bone cysts</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Sex Age</th><th align="center" valign="middle" >Location</th><th align="center" valign="middle" >Volume</th><th align="center" valign="middle" >Treatment DBF/BM</th><th align="center" valign="middle" >Result follow-up</th></tr></thead><tr><td align="center" valign="middle" >M 27 y</td><td align="center" valign="middle" >Humerus, multiple fractures and interventions since age 6 y including plate osteosynthesis</td><td align="center" valign="middle" >18 cc</td><td align="center" valign="middle" >DBF 15 cc/BM 5 cc</td><td align="center" valign="middle" >At 2 years f/u well filled cyst <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="center" valign="middle" >F 22 y</td><td align="center" valign="middle" >Humerus</td><td align="center" valign="middle" >18 cc</td><td align="center" valign="middle" >DBF 10 cc/BM 10 cc</td><td align="center" valign="middle" >2.5 years f/u restitution</td></tr><tr><td align="center" valign="middle" >F 16 y</td><td align="center" valign="middle" >Iliac bone</td><td align="center" valign="middle" >133 cc</td><td align="center" valign="middle" >1<sup>st</sup> Intervention at age 16 years: DBM 40 cc/platelet rich plasma 12 cc 2<sup>nd</sup> intervention at age 21 y DBF 15 cc/BM 5 cc</td><td align="center" valign="middle" >At 2 years f/u after 2<sup>nd </sup> intervention partial bone restitution no pain</td></tr><tr><td align="center" valign="middle" >F 24 y</td><td align="center" valign="middle" >Femoral neck</td><td align="center" valign="middle" >14 cc</td><td align="center" valign="middle" >DBF 12 cc/BM 8 cc</td><td align="center" valign="middle" >At 8 months partial restitution</td></tr><tr><td align="center" valign="middle" >M 21 y</td><td align="center" valign="middle" >Pathologic fracture femur. Cyst unchanged 3 years after osteosynthesis</td><td align="center" valign="middle" >102 cc</td><td align="center" valign="middle" >1<sup>st</sup> Intervention at 21 years DBM 10 cc/platelet rich plasma 2<sup>nd</sup> intervention at 22 years DBF 20 cc/BM 20 cc</td><td align="center" valign="middle" >At 4 years f/u complete restitution <xref ref-type="fig" rid="fig5">Figure 5</xref></td></tr><tr><td align="center" valign="middle" >F 18 y</td><td align="center" valign="middle" >Calcaneus</td><td align="center" valign="middle" >20 cc</td><td align="center" valign="middle" >DBF 12 cc/BM 12 cc</td><td align="center" valign="middle" >At 1 year f/u well filled cyst</td></tr><tr><td align="center" valign="middle" >F 19 y</td><td align="center" valign="middle" >Calcaneus</td><td align="center" valign="middle" >10 cc</td><td align="center" valign="middle" >DBF 9 cc/BM 9 cc</td><td align="center" valign="middle" >At 2 years minimal sclerosis. No symptoms <xref ref-type="fig" rid="fig6">Figure 6</xref></td></tr><tr><td align="center" valign="middle" >M 15 y</td><td align="center" valign="middle" >Calcaneus</td><td align="center" valign="middle" >6 cc</td><td align="center" valign="middle" >DBF 9 cc/BM 8 cc</td><td align="center" valign="middle" >At 8 months f/u clinically asymptomatic</td></tr></tbody></table></table-wrap><p>DBF—Grafton<sup>&#226;</sup> DBF Putty, DBM—Demineralized Bone Matrix, BM—Bone Marrow aspirate. Volume calculated based on the radii of an elliptoid body: a &#215; b &#215; c &#215; d &#215; π &#215; 4/3.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Aneurysmal Bone Cysts</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Sex/ Age</th><th align="center" valign="middle" >Location</th><th align="center" valign="middle" >Volume</th><th align="center" valign="middle" >Treatment interval after Aethoxysclerol inactivation</th><th align="center" valign="middle" >DBF BM</th><th align="center" valign="middle" >Follow-up</th><th align="center" valign="middle" >Result</th></tr></thead><tr><td align="center" valign="middle" >F 21 y</td><td align="center" valign="middle" >Humerus proximal</td><td align="center" valign="middle" >17 cc</td><td align="center" valign="middle" >10 mo</td><td align="center" valign="middle" >DBF 12 cc BM 12 cc</td><td align="center" valign="middle" >8 mo</td><td align="center" valign="middle" >incorporation in progress</td></tr><tr><td align="center" valign="middle" >M 23 y</td><td align="center" valign="middle" >Trochanter maior</td><td align="center" valign="middle" >90 cc</td><td align="center" valign="middle" >4 mo</td><td align="center" valign="middle" >DBF 40 cc BM 20 cc</td><td align="center" valign="middle" >3 y</td><td align="center" valign="middle" >fully restored <xref ref-type="fig" rid="fig4">Figure 4</xref></td></tr><tr><td align="center" valign="middle" >F 18 y</td><td align="center" valign="middle" >Femoral neck</td><td align="center" valign="middle" >6 cc</td><td align="center" valign="middle" >9 mo</td><td align="center" valign="middle" >DBF 3 cc BM 3 cc</td><td align="center" valign="middle" >2 y</td><td align="center" valign="middle" >restored</td></tr><tr><td align="center" valign="middle" >F 17 y</td><td align="center" valign="middle" >Pubic bone/ acetabulum</td><td align="center" valign="middle" >23 cc</td><td align="center" valign="middle" >6 mo</td><td align="center" valign="middle" >DBF 10 cc BM 10 cc</td><td align="center" valign="middle" >5 y</td><td align="center" valign="middle" >partial restoration no symptoms ice skating <xref ref-type="fig" rid="fig3">Figure 3</xref></td></tr><tr><td align="center" valign="middle" >F 22 y</td><td align="center" valign="middle" >Tibia proximal epiphysis</td><td align="center" valign="middle" >14 cc</td><td align="center" valign="middle" >2 y</td><td align="center" valign="middle" >DBF 12 cc BM 10 cc</td><td align="center" valign="middle" >8 mo</td><td align="center" valign="middle" >incorporation in progress</td></tr></tbody></table></table-wrap><p>DBF—Grafton<sup>&#226;</sup> DBF Putty, DBM—Demineralized Bone Matrix, BM—Bone Marrow Aspirate. Volume calculated based on the radii of an elliptoid body: a &#215; b &#215; c &#215; d &#215; π &#215; 4/3.</p><p>suffered fractures and all are pain free at present. Images of selected cases of UBCs und ABCs are presented in Figures 2-6; imaging findings at follow-up are given in <xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>No adverse reactions to the DBF/BM implant or complications related to technical aspects and the application system were observed.</p></sec><sec id="s4"><title>4. Discussion</title><p>The cause of UBC (synonymously used for juvenile bone cysts or simple bone cysts) is poorly understood. Initially UBC was treated mostly by extensive curettage and bone transfer [<xref ref-type="bibr" rid="scirp.101627-ref3">3</xref>]. Since the introduction of intracystic Corticosteroid-Injection by Scaglietti et al. [<xref ref-type="bibr" rid="scirp.101627-ref4">4</xref>] less invasive methods are now mostly used; among them are intramedullary nailing and steroid injection [<xref ref-type="bibr" rid="scirp.101627-ref5">5</xref>], injection of bioabsorbable bone cement [<xref ref-type="bibr" rid="scirp.101627-ref6">6</xref>] and artificial bone substitutes [<xref ref-type="bibr" rid="scirp.101627-ref7">7</xref>]. However, so far there is no evidence to determine the best method for treatment [<xref ref-type="bibr" rid="scirp.101627-ref8">8</xref>]. One randomized trial comparing intralesional bone marrow and steroid injections showed superiority of the latter [<xref ref-type="bibr" rid="scirp.101627-ref9">9</xref>].</p><p>Good results with the injection of Demineralized Bone Matrix (DBM) mixed with autologous bone marrow aspirate into UBCs were first reported by Rougraff and Kling [<xref ref-type="bibr" rid="scirp.101627-ref1">1</xref>] and confirmed by several studies, e.g. Cho et al. [<xref ref-type="bibr" rid="scirp.101627-ref10">10</xref>] and Gundle et al. [<xref ref-type="bibr" rid="scirp.101627-ref11">11</xref>].</p><p>Grafton<sup>&#226;</sup> DBF Putty was used in our patients because of its superior osteoinductivity and osteoconductivity compared to DBM [<xref ref-type="bibr" rid="scirp.101627-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.101627-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.101627-ref14">14</xref>].</p><p>ABCs are lesions unrelated to UBC exhibiting USP6-rearrangement, a marker involved in the development and spontaneous regression of neoplastic processes [<xref ref-type="bibr" rid="scirp.101627-ref15">15</xref>]. We add our cases of ABC in this study as we use the same treatment principles as in UBC if the standard treatment with Aethoxysclerol and recently augmented by surgiflo [<xref ref-type="bibr" rid="scirp.101627-ref16">16</xref>] has successfully inactivated the process, but no new bone formation shows up after at least 4 months.</p><p>The Kyphon<sup>&#226;</sup> Cement Delivering System developed for the injection of cement in kyphoplasty proved to be a useful device to inject the pasty mixture of DBF/BM under well controlled pressure.</p><p>Drawbacks of this study are the lacking of a control group and the still relatively short f/u.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The technique of percutaneous treatment of inactive cysts appears to be effective, minimally invasive and may be considered as a primary choice instead of large open procedures. The use of Grafton<sup>&#226;</sup> DBF Putty with higher osteoinductive and osteoconductive potential appears to enhance the good results achieved so far with DBM. The minimally invasive injection of the highly viscous paste needs an application system as provided by the Kyphon<sup>&#226;</sup> Cement Delivering System (Medtronic). The presented system has been useful in other bone defects, e.g. after radiofrequency ablation and cystic degenerative changes of fibrous dysplasia.</p></sec><sec id="s6"><title>Patient Consent</title><p>The patients were informed that data from their case would be submitted for publication, and informed consent was obtained.</p></sec><sec id="s7"><title>Acknowledgements</title><p>We gratefully acknowledge the collaboration with Jorge J. Herrero, Sales and Therapy Manager Interventional and Biologics, who has drawn our attention to Grafton<sup>&#226;</sup> DBF Putty and the Kyphon<sup>&#226;</sup> Cement Delivering System as well as for the assistance in the surgical interventions.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest regarding the publication of this paper.</p><p>No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this article.</p></sec><sec id="s9"><title>Cite this paper</title><p>Exner, G.U. and Schai, P.A. (2020) Treatment of Unicameral and Aneurysmal Bone Cysts by Minimally Invasive Percutaneous Injection of Grafton<sup>&#226;</sup> DBF Putty Using the Kyphon<sup>&#226;</sup> Cement Delivery System. Open Journal of Orthopedics, 10, 143-151. https://doi.org/10.4236/ojo.2020.107016</p></sec></body><back><ref-list><title>References</title><ref id="scirp.101627-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Rougraff, B.T. and Kling, T.J. (2002) Treatment of Active Unicameral Bone Cysts with Percutaneous Injection of Demineralized Bone Matrix and Autogenous Bone Marrow. Journal of Bone and Joint Surgery, 84, 921-929. https://doi.org/10.2106/00004623-200206000-00005</mixed-citation></ref><ref id="scirp.101627-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Yandow, S.M., Van de Velde, S.K., Siebert, J. and Perkins, S.L. (2017) The Influence of Aspiration Volume on the Number of Osteoblastic Progenitors Obtained from Bone Marrow in Children. Journal of Pediatric Orthopaedics, 39, 382-386. https://doi.org/10.1097/BPO.0000000000000949</mixed-citation></ref><ref id="scirp.101627-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Neer, C.S., Francis, K.C., Marcove, R.C., Terz, J. and Carbonara, P.N. (1966) Treatment of Unicameral Bone Cyst. A Follow-Up Study of One Hundred Seventy-Five Cases. Journal of Bone and Joint Surgery, 48, 731-745. https://doi.org/10.2106/00004623-196648040-00006</mixed-citation></ref><ref id="scirp.101627-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Scaglietti, O., Marchetti, P.G. and Bartolozzi, P. (1979) The Effects of Methylprednisolone Acetate in the Treatment of Bone Cysts. Results of Three Years Follow-Up. Journal of Bone and Joint Surgery, 61, 200-204. https://doi.org/10.1302/0301-620X.61B2.438272</mixed-citation></ref><ref id="scirp.101627-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, P., Zhu, N., Du, L., Zheng, J., Hu, S. and Xu, B. (2020) Treatment of Simple Bone Cysts of the Humerus by Intramedullary Nailing and Steroid Injection. BMC Musculoskeletal Disorders, 21, Article No. 70. https://doi.org/10.1186/s12891-020-3054-6</mixed-citation></ref><ref id="scirp.101627-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Dong, C., Klimek, P., Abacherli, C., De Rosa, V. and Krieg, A.H. (2020) Percutaneous Cyst Aspiration with Injection of Two Different Bioabsorbable Bone Cements in Treatment of Simple Bone Cysts. Journal of Children’s Orthopaedics, 14, 76-84. https://doi.org/10.1302/1863-2548.14.190155</mixed-citation></ref><ref id="scirp.101627-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Higuchi, T., Yamamoto, M., Shirai, T., Hayashi, K., Takeuchi, A., Kimura, H., Miwa, S., Abe, K., Taniguchi, Y. and Tsuchiya, H. (2018) Treatment Outcomes of Simple Bone Cyst. A Comparative Study of 2 Surgical Techniques Using Artificial Bone Substitutes. Medicine, 97, e0572. https://doi.org/10.1097/MD.0000000000010572</mixed-citation></ref><ref id="scirp.101627-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, J.G., Wang, J., Huang, W.J., Zhang, P., Ding, N. and Shang, J. (2017) Interventions for Treating Simple Bone Cysts in the Long Bones of Children. Cochrane Database and Systemic Reviews, No. 2, CD010847.</mixed-citation></ref><ref id="scirp.101627-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Wright, J.G., Yandow, S., Donaldson, S. and Marley, L. (2008) A Randomized Clinical Trial Comparing Intralesional Bone Marrow and Steroid Injections for Simple Bone Cysts. Journal of Bone and Joint Surgery, 90, 722-730. https://doi.org/10.2106/JBJS.G.00620</mixed-citation></ref><ref id="scirp.101627-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Cho, H.S., Seo, S.H., Park, S.H., Park, J.H., Shin, D.S. and Park, I.H. (2012) Minimal Invasive Surgery for Unicameral Bone Cyst Using Demineralized Bone Matrix: A Case Series. BMC Musculoskeletal Disorders, 13, Article No. 134. https://doi.org/10.1186/1471-2474-13-134</mixed-citation></ref><ref id="scirp.101627-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Gundle, K.R., Bhatt, E.M., Punt, S.E., Bompadre, V. and Conrad, E.U. (2017) Injection of Unicameral Bone Cysts with Bone Marrow Aspirate and Demineralized Bone Matrix Avoids Open Curettage and Bone-Grafting in a Retrospective Cohort. The Open Orthopaedics Journal, 11, 486-492. https://doi.org/10.2174/1874325001711010486</mixed-citation></ref><ref id="scirp.101627-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Edwards, J.T., Diegmann, M.H. and Scarborough, N.L. (1998) Osteoinduction of Human Demineralized Bone: Characterization in a Rat Model. Clinical Orthopaedics and Related Research, 357, 219-228. https://doi.org/10.1097/00003086-199812000-00028</mixed-citation></ref><ref id="scirp.101627-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Martin, G.J., Boden, S.D., Titus, L. and Scarborough, N.L. (1999) New Formulations of Demineralized Bone Matrix as a More Effective Graft Alternative in Experimental Posterolateral Lumbar Spine Arthrodesis. Spine, 24, 637-645. https://doi.org/10.1097/00007632-199904010-00005</mixed-citation></ref><ref id="scirp.101627-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Rodriguez, R.U., Kemper, N., Breathwaite, E., Dutta, S.M., Huber, A., Murchison, A., Chen, S., Hsu, E.I., Hsu, W.K. and Francis, M.P. (2016) Demineralized Bone Matrix Fibers Formable as General and Custom 3D Printed Mold-Based Implants for Promoting Bone Regeneration. Biofabrication, 8, Article ID: 035007. https://doi.org/10.1088/1758-5090/8/3/035007</mixed-citation></ref><ref id="scirp.101627-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Kaiser, E., Fonseca, U.N., Castro, A., Kubo, R.S., Miranda, F.C., Taneja, A.K., Santos, D. and Rosemberg, L.A. (2019) Musculoskeletal “Don’t Touch” Lesions: Pictorial Essay. Radiologia Brasileira, 52, 48-53. https://doi.org/10.1590/0100-3984.2016.0225</mixed-citation></ref><ref id="scirp.101627-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ghanem, I., Nicolas, N., Rizkallah, M. and Slaba, S. (2017) Sclerotherapy Using Surgiflo and Alcohol: A New Alternative for the Treatment of Aneurysmal Bone Cysts. Journal of Children’s Orthopaedics, 11, 448-454. https://doi.org/10.1302/1863-2548.11.170106</mixed-citation></ref></ref-list></back></article>